Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Daxor Corp in August, 2021 for $457,324.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL156731-01 | Phase I | 457,324 | August 1, 2021 | |||||||
A SBIR Phase I contract was awarded to Daxor Corp in March, 2020 for $49,933.0 USD from the U.S. Department of Defense and United States Air Force. | SBIR | FA8649-20-P-0867 | Phase I | 49,933 | March 9, 2020 | |||||||
A SBIR Phase II contract was awarded to Daxor Corp in October, 2019 for $447,603.0 USD from the U.S. Department of Defense and United States Army. | SBIR | W81XWH-20-C-0025 | Phase II | 447,603 | October 31, 2019 | |||||||
A SBIR Phase I contract was awarded to Daxor Corp in October, 2018 for $145,168.75 USD from the U.S. Department of Defense and United States Army. | SBIR | W81XWH-19-C-0048 | Phase I | 145,168.75 | October 15, 2018 | |||||||
A SBIR Phase II contract was awarded to Daxor Corp in March, 2021 for $749,967.0 USD from the U.S. Department of Defense and United States Air Force. | SBIR | FA8649-21-P-0830 | Phase II | 749,967 | March 11, 2021 | |||||||
A SBIR Phase I contract was awarded to Daxor Corp in September, 2023 for $305,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM149094-01 | Phase I | 305,000 | September 1, 2023 | |||||||
A SBIR Phase II contract was awarded to Daxor Corp in June, 2023 for $1,099,997.0 USD from the U.S. Department of Defense and Defense Health Agency. | SBIR | HT9425-23-C-0050 | Phase II | 1,099,997 | June 29, 2023 |